Intra-Cellular Therapies Quarterly Balance Sheets Chart
Quarterly
|
Annual
Intra-Cellular Therapies Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 306,948,000 | 464,312,000 | 693,306,000 | 139,819,000 | 147,767,000 | 99,402,000 | 142,258,000 | 75,727,000 | 148,615,000 | 135,358,000 | 77,235,000 | 129,295,000 | 92,364,990 | 106,125,959 | 121,030,152 | 129,979,888 | 60,045,933 | 300,988,981 | 129,290,445 | 179,593,032 | 107,636,849 | 102,162,982 | 91,763,368 | 64,091,080 | 54,947,502 | 69,776,956 | 69,767,045 | 74,421,386 | 37,790,114 | 52,340,519 | 29,590,446 | 23,598,325 | 48,642,225 | 200,388,020 | 51,972,773 | 37,240,565 | 47,159,303 | 332,828,289 | 71,418,286 | 100,802,133 | 61,325,044 | 68,915,333 | 91,140,138 | 143,618,247 | 35,150,924 | 44,072,012 | |
| investment securities, available-for-sale | 694,118,000 | 542,250,000 | 329,601,000 | 335,804,000 | 350,174,000 | 393,619,000 | 370,596,000 | 462,981,000 | 443,290,000 | 493,383,000 | 600,594,000 | 642,553,000 | 319,968,348 | 371,157,974 | 433,727,230 | 481,984,786 | 597,402,126 | 420,958,509 | 278,468,502 | 269,360,926 | 116,373,335 | 153,270,596 | 193,536,800 | 248,731,291 | 292,583,046 | 306,211,066 | 333,997,440 | 362,584,126 | 426,540,921 | 275,781,285 | 313,037,669 | 344,183,051 | 335,458,459 | 337,405,780 | 390,717,316 | 418,827,867 | 428,041,021 | 177,903,693 | 132,570,900 | 134,424,335 | 68,320,672 | 67,066,729 | 49,355,284 | ||||
| restricted cash | 1,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,400,000 | 1,400,000 | 1,400,000 | 1,400,000 | 1,400,000 | 1,400,000 | 1,400,000 | 1,400,000 | 1,400,000 | 1,400,000 | |||||||||||||||||||||||||||
| accounts receivable | 166,500,000 | 145,608,000 | 145,714,000 | 131,157,000 | 114,018,000 | 102,670,000 | 95,964,000 | 81,545,000 | 75,189,000 | 61,538,000 | 46,976,000 | 32,832,000 | 20,155,994 | 16,934,352 | 7,480,604 | 2,353,255 | 1,351,013 | 6,309 | 61,935 | 68,200 | 94,339 | 1,309 | 98,240 | 30,660 | 9,118 | 3,315 | 51,603 | 124,414 | 219,238 | 167,787 | 336,318 | 251,291 | |||||||||||||||
| inventory | 26,283,000 | 23,539,000 | 20,082,000 | 15,949,000 | 11,647,000 | 42,986,000 | 41,895,000 | 28,341,000 | 23,920,000 | 23,597,000 | 25,022,000 | 7,893,000 | 7,948,126 | 8,166,935 | 7,768,848 | 7,579,393 | 7,056,385 | 2,947,138 | 2,335,042 | 1,391,124 | |||||||||||||||||||||||||||
| prepaid expenses and other current assets | 111,765,000 | 94,272,000 | 73,798,000 | 66,048,000 | 42,443,000 | 61,998,000 | 45,610,000 | 55,750,000 | 45,193,000 | 44,130,000 | 37,979,000 | 34,369,000 | 25,443,372 | 29,457,445 | 22,189,200 | 14,494,384 | 14,235,455 | 11,090,774 | 4,726,134 | 7,876,405 | 6,313,785 | 4,023,348 | 3,041,730 | 8,305,259 | 7,908,133 | 7,265,428 | 5,896,583 | 6,148,067 | 4,884,293 | 5,307,357 | 6,144,819 | 3,761,282 | 4,005,093 | 4,023,405 | 4,020,092 | 6,790,104 | 8,025,147 | 1,532,908 | 8,612,651 | 1,267,369 | 1,288,953 | 1,374,378 | 493,356 | 585,104 | 762,243 | 806,288 | |
| total current assets | 1,307,364,000 | 1,271,731,000 | 1,264,251,000 | 690,527,000 | 667,799,000 | 702,425,000 | 698,073,000 | 706,094,000 | 737,957,000 | 759,756,000 | 789,206,000 | 848,342,000 | 467,280,830 | 533,242,665 | 601,303,244 | 649,100,443 | 690,904,482 | 744,866,006 | 418,573,378 | 460,972,500 | 230,323,969 | 259,456,926 | 288,341,898 | 321,127,630 | 355,438,681 | 383,253,450 | 409,661,068 | 443,153,579 | 469,215,328 | 333,435,470 | 348,834,869 | 371,610,858 | 388,200,116 | 541,818,514 | 446,808,421 | 462,858,536 | 483,256,131 | 512,264,890 | 212,610,955 | 236,497,152 | 130,986,272 | 137,480,854 | 141,208,016 | 146,371,138 | 38,249,485 | 47,129,591 | 49 |
| property and equipment | 1,468,000 | 2,005,000 | 1,445,000 | 1,522,000 | 1,654,000 | 1,789,000 | 1,656,000 | 1,779,000 | 1,913,000 | 2,084,000 | 2,137,000 | 2,185,000 | 1,790,724 | 1,936,308 | 1,761,001 | 1,871,338 | 1,998,346 | 2,049,552 | 2,000,687 | 2,132,987 | 2,259,740 | 2,174,993 | 2,082,933 | 1,125,606 | 1,159,766 | 1,196,480 | 1,275,387 | 1,349,765 | 1,137,171 | 679,606 | 628,901 | 605,683 | 627,614 | 677,703 | 718,659 | 731,429 | 775,522 | 785,544 | 722,131 | 559,709 | 54,553 | 57,440 | 63,850 | 65,075 | 68,272 | 75,700 | |
| right of use assets | 13,428,000 | 14,011,000 | 14,507,000 | 12,481,000 | 12,928,000 | 13,364,000 | 13,787,000 | 14,199,000 | 14,824,000 | 20,073,000 | 20,477,000 | 17,967,000 | 20,764,458 | 21,710,677 | 22,546,333 | 23,430,703 | 24,324,762 | 24,292,167 | 20,270,675 | 18,051,146 | 18,252,074 | 18,540,418 | 18,822,482 | 20,104,280 | |||||||||||||||||||||||
| inventory, non-current | 38,890,000 | 30,479,000 | 32,562,000 | 34,818,000 | 38,621,000 | ||||||||||||||||||||||||||||||||||||||||||
| other assets | 5,762,000 | 6,219,000 | 7,739,000 | 7,688,000 | 7,293,000 | 86,000 | 86,000 | 86,000 | 86,000 | 86,000 | 86,000 | 86,000 | 86,084 | 86,084 | 86,084 | 86,084 | 86,084 | 86,084 | 86,084 | 86,084 | 86,084 | 86,084 | 86,083 | 86,083 | 78,833 | 78,833 | 78,833 | 77,293 | 75,765 | 75,765 | 75,765 | 75,765 | 75,765 | 75,765 | 75,765 | 71,875 | 71,875 | 71,875 | 70,944 | 70,944 | 70,944 | 70,944 | 70,944 | 200,447 | 131,555 | 130,755 | |
| total assets | 1,366,912,000 | 1,324,445,000 | 1,320,504,000 | 747,036,000 | 728,295,000 | 717,664,000 | 713,602,000 | 722,158,000 | 754,780,000 | 781,999,000 | 811,906,000 | 868,580,000 | 489,922,096 | 556,975,734 | 625,696,662 | 674,488,568 | 717,313,674 | 771,293,809 | 440,930,824 | 481,242,717 | 251,186,476 | 280,523,030 | 309,862,614 | 342,972,817 | 357,206,498 | 385,587,198 | 412,073,723 | 445,639,072 | 471,486,699 | 334,190,841 | 349,539,535 | 372,292,306 | 388,903,495 | 542,571,982 | 447,602,845 | 463,661,840 | 484,103,528 | 513,122,309 | 213,404,030 | 237,127,805 | 131,111,769 | 137,609,238 | 141,342,810 | 146,636,660 | 38,449,312 | 47,336,046 | 49 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 26,074,000 | 10,338,000 | 17,548,000 | 11,532,000 | 11,452,000 | 10,613,000 | 7,733,000 | 8,441,000 | 10,395,000 | 14,219,000 | 10,749,000 | 11,649,000 | 8,691,220 | 12,030,614 | 15,940,756 | 8,720,957 | 5,501,825 | 8,569,148 | 5,472,987 | 10,994,082 | 7,425,024 | 6,230,923 | 5,632,783 | 8,574,433 | 13,961,060 | 10,453,186 | 5,378,870 | 10,038,850 | 6,173,539 | 4,407,655 | 1,775,252 | 7,157,746 | 3,754,647 | 5,417,451 | 3,889,566 | 1,959,272 | 1,632,905 | 705,043 | 4,911,065 | 4,574,351 | 2,052,765 | 503,882 | 415,791 | 2,142,779 | 3.395 | 4,027,097 | |
| accrued and other current liabilities | 65,215,000 | 51,540,000 | 39,713,000 | 33,249,000 | 27,944,000 | 27,829,000 | 27,456,000 | 21,067,000 | 19,657,000 | 14,850,000 | 17,274,000 | 12,258,000 | 11,072,996 | 16,928,669 | 14,054,009 | 13,491,620 | 10,902,117 | 12,186,380 | 19,383,111 | 10,667,765 | 16,138,909 | 17,323,632 | 18,801,485 | 18,700,638 | 20,044,866 | 14,168,130 | 10,462,217 | 7,355,955 | 6,424,221 | 4,151,120 | 2,781,198 | 7,039,115 | 5,329,293 | 7,520,073 | 12,981,891 | 5,241,839 | 3,423,464 | 8,575,333 | 3,340,399 | 9,029,493 | 7,529,241 | 2,143,756 | 1,434,875 | 940,594 | 2,611,091 | 2,571,126 | |
| accrued customer programs | 75,408,000 | 70,536,000 | 77,971,000 | 69,972,000 | 53,173,000 | 35,618,000 | 31,710,000 | 29,892,000 | 25,621,000 | 19,946,000 | 16,483,000 | 10,888,000 | 5,963,610 | ||||||||||||||||||||||||||||||||||
| accrued employee benefits | 34,774,000 | 29,496,000 | 22,372,000 | 16,409,000 | 27,364,000 | 25,448,000 | 21,623,000 | 16,656,000 | 22,996,000 | 21,150,000 | 18,385,000 | 16,643,000 | 20,896,860 | 14,854,226 | 14,832,115 | 11,915,893 | 14,907,479 | 12,005,931 | 11,412,697 | 6,203,283 | 9,472,651 | 7,531,659 | 5,829,242 | 3,351,208 | 2,293,259 | 4,507,580 | 3,094,280 | 2,257,963 | 1,611,846 | 3,316,378 | 2,406,269 | 2,121,795 | 1,448,394 | 2,752,381 | 2,509,611 | 1,745,561 | 1,207,143 | 1,106,620 | 1,066,629 | 988,897 | 975,058 | 929,963 | 888,588 | 828,262 | 827,879 | 759,757 | |
| operating lease liabilities | 4,233,000 | 4,203,000 | 4,171,000 | 3,639,000 | 3,612,000 | 3,584,000 | 3,558,000 | 3,531,000 | 4,567,000 | ||||||||||||||||||||||||||||||||||||||
| total current liabilities | 205,704,000 | 166,113,000 | 161,775,000 | 134,801,000 | 123,545,000 | 103,092,000 | 92,080,000 | 79,587,000 | 83,236,000 | 77,410,000 | 70,634,000 | 59,074,000 | 53,356,478 | 49,895,563 | 50,421,937 | 39,701,710 | 36,853,223 | 38,028,717 | 40,242,715 | 31,076,364 | 36,224,019 | 33,373,099 | 32,526,487 | 33,499,301 | 36,299,185 | 29,128,896 | 18,935,367 | 19,652,768 | 14,209,606 | 11,875,153 | 6,962,719 | 16,318,656 | 10,532,334 | 140,689,905 | 19,381,068 | 8,946,672 | 6,263,512 | 10,386,996 | 9,318,093 | 14,592,741 | 10,557,064 | 3,577,601 | 2,739,254 | 3,911,635 | 6,834,037 | 7,774,662 | 33,032 |
| operating lease liabilities, non-current | 12,748,000 | 13,506,000 | 14,117,000 | 12,737,000 | 13,326,000 | 13,891,000 | 14,432,000 | 14,961,000 | |||||||||||||||||||||||||||||||||||||||
| total liabilities | 218,452,000 | 179,619,000 | 175,892,000 | 147,538,000 | 136,871,000 | 116,983,000 | 106,512,000 | 94,548,000 | 98,710,000 | 96,577,000 | 89,709,000 | 75,830,000 | 72,031,421 | 70,219,481 | 72,110,788 | 62,338,810 | 60,453,570 | 61,898,274 | 61,400,956 | 50,794,387 | 56,179,205 | 53,642,745 | 53,094,252 | 54,358,390 | 39,491,617 | 31,961,802 | 21,686,281 | 22,450,117 | 17,049,738 | 14,750,765 | 9,873,811 | 19,265,229 | 13,400,956 | 143,253,714 | 21,640,064 | 10,917,419 | 7,860,617 | 11,268,139 | 9,838,721 | 14,752,853 | |||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 11,000 | 11,000 | 11,000 | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 | 9,000 | 9,000 | 9,000 | 9,000 | 8,189 | 8,138 | 8,132 | 8,113 | 8,046 | 8,014 | 6,678 | 6,620 | 5,551 | 5,525 | 5,519 | 5,513 | 5,490 | 5,471 | 5,470 | 5,469 | 5,460 | 4,342 | 4,342 | 4,342 | 4,329 | 4,327 | 4,325 | 4,323 | 4,316 | 4,301 | 3,504 | 3,497 | 2,950 | 2,940 | 2,934 | 2,922 | 2,216 | 2,213 | 500 |
| additional paid-in capital | 2,840,094,000 | 2,818,137,000 | 2,793,896,000 | 2,232,325,000 | 2,208,470,000 | 2,190,587,000 | 2,173,671,000 | 2,151,837,000 | 2,137,737,000 | 2,124,369,000 | 2,106,942,000 | 2,089,418,000 | 1,639,475,837 | 1,622,149,674 | 1,611,989,381 | 1,601,739,075 | 1,593,475,506 | 1,585,023,637 | 1,199,576,320 | 1,188,095,880 | 904,971,772 | 896,191,230 | 891,183,518 | 885,888,318 | 880,753,339 | 876,094,265 | 871,516,637 | 867,152,094 | 862,479,505 | 696,695,317 | 694,146,861 | 689,723,391 | 685,290,815 | 681,475,390 | 677,623,643 | 673,679,915 | 669,878,103 | 666,083,825 | 335,668,581 | 332,948,140 | 208,912,345 | 207,152,913 | 205,289,691 | 204,829,884 | 89,177,556 | 89,082,858 | 9,500 |
| accumulated deficit | -1,691,836,000 | -1,674,951,000 | -1,648,627,000 | -1,632,407,000 | -1,617,160,000 | -1,588,581,000 | -1,564,323,000 | -1,521,539,000 | -1,477,486,000 | -1,433,460,000 | -1,379,952,000 | -1,293,349,000 | -1,221,229,698 | -1,135,495,761 | -1,058,587,757 | -989,843,975 | -937,104,032 | -876,404,854 | -821,221,229 | -757,508,971 | -710,098,369 | -669,515,518 | -634,653,119 | -597,211,954 | -562,376,191 | -521,628,155 | -480,105,241 | -442,728,858 | -407,248,780 | -377,040,068 | -354,169,652 | -336,408,948 | -309,475,366 | -281,990,327 | -251,725,000 | -220,890,547 | -193,049,098 | -164,214,582 | -132,054,099 | -110,542,781 | -88,255,957 | -73,056,827 | -66,641,320 | -62,107,781 | -57,564,497 | -49,523,687 | |
| accumulated comprehensive income | 191,000 | 1,629,000 | -668,000 | -430,000 | 104,000 | -363,653 | 94,202 | 176,118 | 246,545 | 480,584 | 768,738 | 1,168,099 | |||||||||||||||||||||||||||||||||||
| total stockholders’ equity | 1,148,460,000 | 1,144,826,000 | 1,144,612,000 | 599,498,000 | 591,424,000 | 600,681,000 | 607,090,000 | 627,610,000 | 656,070,000 | 685,422,000 | 722,197,000 | 792,750,000 | 417,890,675 | 486,756,253 | 553,585,874 | 612,149,758 | 656,860,104 | 709,395,535 | 379,529,868 | 430,448,330 | 195,007,271 | 226,880,285 | 256,768,362 | 288,614,427 | 317,714,881 | 353,625,396 | 390,387,442 | 423,188,955 | 454,436,961 | 319,440,076 | 339,665,724 | 353,027,077 | 375,502,539 | 399,318,268 | 425,962,781 | 452,744,421 | 476,242,911 | 501,854,170 | 203,565,309 | 222,374,952 | 120,554,705 | 134,031,637 | 138,603,556 | 142,725,025 | 31,615,275 | 39,561,384 | |
| total liabilities and stockholders’ equity | 1,366,912,000 | 1,324,445,000 | 1,320,504,000 | 747,036,000 | 728,295,000 | 717,664,000 | 713,602,000 | 722,158,000 | 754,780,000 | 781,999,000 | 811,906,000 | 868,580,000 | 489,922,096 | 556,975,734 | 625,696,662 | 674,488,568 | 717,313,674 | 771,293,809 | 440,930,824 | 481,242,717 | 251,186,476 | 280,523,030 | 309,862,614 | 342,972,817 | 357,206,498 | 385,587,198 | 412,073,723 | 445,639,072 | 471,486,699 | 334,190,841 | 349,539,535 | 372,292,306 | 388,903,495 | 542,571,982 | 447,602,845 | 463,661,840 | 484,103,528 | 513,122,309 | 213,404,030 | 237,127,805 | 131,111,769 | 137,609,238 | 141,342,810 | 146,636,660 | 38,449,312 | 47,336,046 | |
| accumulated comprehensive loss | -1,335,000 | -2,268,000 | -2,698,000 | -4,190,000 | -5,496,000 | -4,802,000 | -3,328,000 | -67,450 | -667,757 | -846,185 | -1,029,424 | -1,239,750 | -799,224 | -219,515 | -315,827 | -291,708 | -317,239 | -171,122 | -49,270 | -590,410 | -19,374 | -52,677 | -33,904 | -104,633 | |||||||||||||||||||||||
| operating lease liabilities, non-current, | 15,474,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| lease liabilities, short-term | 7,245,000 | 7,743,000 | 7,636,000 | 6,731,792 | 6,082,054 | 5,595,057 | 5,573,240 | 5,541,802 | 5,267,258 | 3,973,920 | 3,211,234 | 3,187,435 | 2,286,885 | 2,262,977 | 2,873,022 | ||||||||||||||||||||||||||||||||
| lease liabilities | 19,167,000 | 19,075,000 | 16,756,000 | 18,674,943 | 20,323,918 | 21,688,851 | 22,637,100 | 23,600,347 | 23,869,557 | 21,158,241 | 19,718,023 | 19,955,186 | 20,269,646 | 20,567,765 | |||||||||||||||||||||||||||||||||
| accounts receivable, net of 120,000 allowance at june 30, 2021 and december 31, 2020 | 15,187,814 | ||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, net of 120,000 allowance at march 31, 2021 and december 31, 2020 | 13,661,992 | ||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivables | 10,764,583 | ||||||||||||||||||||||||||||||||||||||||||||||
| deferred tax asset | 264,609 | 264,609 | 529,218 | ||||||||||||||||||||||||||||||||||||||||||||
| accumulated comprehensive gain | -145,199 | 59,813 | |||||||||||||||||||||||||||||||||||||||||||||
| deferred rent | |||||||||||||||||||||||||||||||||||||||||||||||
| accumulated comprehensive gain/ | 128,317 | 199,048 | 232,444 | ||||||||||||||||||||||||||||||||||||||||||||
| long term deferred tax asset | 529,218 | 529,218 | 1,058,435 | 1,058,435 | 1,058,435 | 1,058,435 | |||||||||||||||||||||||||||||||||||||||||
| long-term deferred rent | 3,192,432 | 2,832,906 | 2,750,914 | 2,797,349 | 2,840,132 | 2,868,622 | 1,597,105 | 881,143 | 520,628 | ||||||||||||||||||||||||||||||||||||||
| long-term lease liabilities | 20,859,089 | ||||||||||||||||||||||||||||||||||||||||||||||
| long-term liabilities | 2,875,612 | 2,911,092 | 2,946,573 | 2,563,809 | 2,258,996 | 1,970,747 | 160,112 | ||||||||||||||||||||||||||||||||||||||||
| borrowing under secured line of credit | 125,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -67,389 | -47,749 | |||||||||||||||||||||||||||||||||||||||||||||
| certificates of deposit | 2,000,000 | 2,000,000 | 2,000,000 | ||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue—short-term | |||||||||||||||||||||||||||||||||||||||||||||||
| liabilities, redeemable convertible preferred stock, and stockholders’ deficit | |||||||||||||||||||||||||||||||||||||||||||||||
| deferred revenue | 416,682 | ||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||
| cash | 49 | ||||||||||||||||||||||||||||||||||||||||||||||
| liabilities and stockholder's deficiency | |||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses | 23,732 | ||||||||||||||||||||||||||||||||||||||||||||||
| loan payable - related party | 3,400 | ||||||||||||||||||||||||||||||||||||||||||||||
| note payable - related party | 5,900 | ||||||||||||||||||||||||||||||||||||||||||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||
| stockholder's deficiency: | |||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, .0001 par value; 10,000,000 shares authorized; none issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||
| accumulated deficit during the development stage | -42,983 | ||||||||||||||||||||||||||||||||||||||||||||||
| total stockholder's deficiency | -32,983 | ||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities and stockholder's equity | 49 |
We provide you with 20 years of balance sheets for Intra-Cellular Therapies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Intra-Cellular Therapies. Explore the full financial landscape of Intra-Cellular Therapies stock with our expertly curated balance sheets.
The information provided in this report about Intra-Cellular Therapies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.